ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Aurora kinase A regulates cancer-associated RNA aberrant splicing in breast cancer

Li, Sisi*; Qi, Yangfan; Yu, Jiachuan; Hao, Yuchao; Xu, Lingzhi; Ding, Xudong; Zhang, Minghui*; Geng, Jingshu*哈尔滨医科大学; 1
Heliyon2023-7DOI: 10.1016/j.heliyon.2023.e17386
1被引11阅读
引用收藏
分享

摘要

The contribution of oncogenes to tumor-associated RNA splicing and the relevant molecular mechanisms therein require further elaboration. Here, we show that oncogenic Aurora kinase A (AURKA) promotes breast cancer-related RNA aberrant splicing in a context-dependent manner. AURKA regulated pan-breast cancer-associated RNA splicing events including GOLGA4, RBM4 and UBQLN1. Aberrant splicing of GOLGA4 and RBM4 was closely related to breast cancer development. Mechanistically, AURKA interacted with the splicing factor YBX1 and promoted AURKA-YBX1 complex-mediated GOLGA4 exon inclusion. AURKA binding to the splicing factor hnRNPK promoted AURKA-hnRNPK complex-mediated RBM4 exon skipping. Analysis of clinical data identified an association between the AURKA-YBX1/hnRNPK complex and poor prognosis in breast cancer. Blocking AURKA nuclear translocation with small molecule drugs partially reversed the oncogenic splicing of RBM4 and GOLGA4 in breast cancer cells. In summary, oncogenic AURKA executes its function on modulating breast cancer-related RNA splicing, and nuclear AURKA is distinguished as a hopeful target in the case of treating breast cancer.

学科与关键词

关键词
Aurora kinase ARNA splicingSplicing factorBreast cancer
相关
加载中…
  • Nuclear Aurora kinase A switches m6A reader YTHDC1 to enhance an oncogenic RNA splicing of tumor suppressor RBM4
    Li, SiSi; Qi, YangFan; Yu, JiaChuan; Hao, YuChao; He, Bin; Zhang, MengJuan; Dai, ZhenWei; Jiang, TongHui; Li, SuYi; Huang, Fang; Chen, Ning; Wang, Jing; Yang, MengYing; Liang, DaPeng; An, Fan; Zhao, JinYao; Fan, WenJun; Pan, YuJia; Deng, ZiQian; Luo, YuanYuan; Guo, Tao; Peng, Fei; Hou, ZhiJie; Wang, ChunLi; Zheng, FeiMeng; Xu, LingZhi; Xu, Jie; Wen, QingPing; Jin, BiLian*; Wang, Yang*; Liu, Quentin*Signal Transduction and Targeted Therapy, 2022, 7(1): 97.被引 28
  • Mutant SF3B1 promotes AKT- and NF-κB-driven mammary tumorigenesis.
    Liu, Bo; Liu, Zhaoqi; Chen, Sisi; Ki, Michelle; Erickson, Caroline; Reis-Filho, Jorge S; Durham, Benjamin H; Chang, Qing; de Stanchina, Elisa; Sun, Yiwei; Rabadan, Raul; Abdel-Wahab, Omar; Chandarlapaty, SaratJournal of Clinical Investigation, 2021, 131(1).
  • Acylglycerol kinase promotes cell proliferation and tumorigenicity in breast cancer via suppression of the FOXO1 transcription factor
    Wang Xi; Lin Chuyong; Zhao Xiaohui; Liu Aibin; Zhu Jinrong; Li Xinghua; Song Libing*Molecular Cancer, 2014, 13: 106.被引 11
查看全部 →

发表信息

论文状态
公开发表
期刊
Heliyon
发表日期
2023-07
卷期
第 9 卷, 第 7 期
页码
e17386
DOI
10.1016/j.heliyon.2023.e17386
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82103659, 8210113819]; Postdoctoral Foundation of Hei Long Jiang Province [LBH-Z20074]; Harbin Medical University Doctor Green Seedling Ground -breaking Project [QMPT-1909]; Natural Science Foundation of Inner Mongolia [2020MS08084]; Inner Mongolia Science amp; Technology Plan Project [2020GG0297]

作者

  • L

    Li, Sisi (通讯) (第一作者)

    harbin med univ · dalian med univ

  • Q

    Qi, Yangfan

    dalian med univ

查看全部 8 位作者收起作者
  • Y

    Yu, Jiachuan

    1 · dalian med univ

  • H

    Hao, Yuchao

    dalian med univ

  • X

    Xu, Lingzhi

    2 · dalian med univ

  • D

    Ding, Xudong

    2 · dalian med univ

  • Z

    Zhang, Minghui (通讯)

  • G

    Geng, Jingshu (通讯)

    harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417